DAX23.970 -1,0%ESt505.338 -0,3%Top 10 Crypto16,23 +2,0%Dow44.762 -0,3%Nas21.138 +0,1%Bitcoin101.610 ±0,0%Euro1,1593 -1,3%Öl70,22 +2,7%Gold3.316 -0,6%

25 € Neukundenbonus + 1 Aktie gratis. Hol Dir jetzt Dein finanzen.net ZERO-Depot!

Savara Aktie

Kaufen

Verkaufen

Handeln Handeln

Savara Aktien-Sparplan Savara Aktien-Sparplan

2,18 EUR ±0,00 EUR ±0,00 %

08:02:58

FSE

2,68 USD +0,10 USD +3,68 %

21:10:57

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Smartphone

Marktkap.380,28 Mio. EUR

Div. Rendite0,00%

WKNA2DQ2B

ISINUS8051111016

SymbolSVRA

Savara Aktien News

Sortieren:Datum Meistgelesen

06.10.23BusinesswireSavara Announces New Employment Inducement Grant

05.09.23BusinesswireSavara to Present at the H.C. Wainwright 25th Annual Global Investment Conference

10.08.23BusinesswireSavara Reports Second Quarter Financial Results and Provides Business Update

04.08.23BusinesswireSavara Announces New Employment Inducement Grant

13.07.23BusinesswireSavara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

26.06.23BusinesswireSavara Added to Russell 3000® Index

26.06.23BusinesswireSavara Completes Enrollment of Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

02.06.23BusinesswireSavara to Present at the Jefferies Healthcare Conference

15.05.23BusinesswireSavara Reports First Quarter Financial Results and Provides Business Update

05.05.23BusinesswireSavara Announces New Employment Inducement Grant

31.03.23BusinesswireSavara Announces New Employment Inducement Grant

30.03.23BusinesswireSavara Reports Fourth Quarter / Year-End 2022 Financial Results and Provides Business Update

06.03.23BusinesswireSavara to Present at the Oppenheimer 33rd Annual Healthcare Conference

28.02.23BusinesswireSavara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

14.02.23BusinesswireSavara Announces New Leadership Appointments

20.01.23BusinesswireSavara Announces New Employment Inducement Grant

22.11.22BusinesswireSavara Announces New Employment Inducement Grant

10.11.22BusinesswireSavara Reports Third Quarter 2022 Financial Results and Provides Business Update

09.11.22BusinesswireSavara to Participate in Three Upcoming Investor Conferences

14.09.22BusinesswireSavara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

06.09.22BusinesswireSavara Presented Data at the European Respiratory Society (ERS) International Congress 2022

01.09.22BusinesswireSavara to Present at H.C. Wainwright 24th Annual Global Investment Conference

26.08.22BusinesswireSavara Announces Resignation of Chief Medical Officer

25.08.22BusinesswireSavara Awarded Promising Innovative Medicine (PIM) Designation in the United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

11.08.22BusinesswireSavara Reports Second Quarter 2022 Financial Results and Provides Business Update

Savara News

Savara News: auf dieser Seite finden Sie alle Savara News und Nachrichten zur Savara Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Savara News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Savara News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.